Ignite Creation Date:
2024-05-06 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05716295
Status:
TERMINATED
Last Update Posted:
2024-05-08
First Post:
2023-01-19
Brief Title:
A Dose EscalationExpansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors
Sponsor:
Medikine Inc
Organization:
Medikine Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced or Metastatic Solid Tumors |
Keywords:
| Name | View |
|---|---|
| MDK-703 | View |
| IL-7 | View |
| Interleukin 7 | View |
| Interleukin-7 | View |
| IL7 | View |
| oncology | View |
| immuno-oncology | View |
| immunotherapy | View |
| solid tumor | View |
| advanced solid tumor | View |
| metastatic solid tumor | View |
| neoplasms | View |
| solid malignancies | View |
| pancreatic cancer | View |
| PDAC | View |
| MSS-CRC | View |
| microsatellite stable CRC | View |
| microsatellite stable colorectal cancer | View |
| prostate cancer | View |
| breast cancer | View |
| ovarian cancer | View |
| immune cold | View |